MedPath

Examination about the combination medical treatment of the antihypertensive drug which assumed extraneous blood pressure an index

Not Applicable
Conditions
hypertension
Registration Number
JPRN-UMIN000007156
Lead Sponsor
Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

secondary hypertension angina pectoris severe heart disease severe diabetic mellitus (HbA1c > 10%) severe liver disease (AST or ALT > 100U/L) malignancy allergy for olmesartan medoxomil or azelnidipine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Achievement rate of antihypertensive therapy which assumed extraneous blood pressure in JSH2009 an index
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath